158 related articles for article (PubMed ID: 36333461)
21. Clinical characteristics and prognostic risk factors of healthcare-associated pneumonia in a Korean tertiary teaching hospital.
Ahn JH; Lee KH; Chung JH; Shin KC; Lee CK; Kim HJ; Choi EY
Medicine (Baltimore); 2017 Oct; 96(42):e8243. PubMed ID: 29049213
[TBL] [Abstract][Full Text] [Related]
22. Impact of prior pulmonary tuberculosis in treatment outcomes of HCAP and CAP patients in intensive care units.
Lin FM; Feng JY; Fang WF; Wu CL; Yu CJ; Lin MC; Ku SC; Chen CW; Tu CY; Yang KY
J Microbiol Immunol Infect; 2019 Apr; 52(2):320-328. PubMed ID: 30245205
[TBL] [Abstract][Full Text] [Related]
23. Risk factors to predict drug-resistant pathogens in hemodialysis-associated pneumonia.
Wang PH; Wang HC
BMC Infect Dis; 2016 Aug; 16():377. PubMed ID: 27502599
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia.
Kollef MH; Shorr A; Tabak YP; Gupta V; Liu LZ; Johannes RS
Chest; 2005 Dec; 128(6):3854-62. PubMed ID: 16354854
[TBL] [Abstract][Full Text] [Related]
25. Quality pneumonia care: distinguishing community-acquired from health care-associated pneumonia.
Shorr AF; Owens RC
Am J Health Syst Pharm; 2009 Jun; 66(12 Suppl 4):S8-14. PubMed ID: 19502227
[TBL] [Abstract][Full Text] [Related]
26. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
Polverino E; Torres A; Menendez R; Cillóniz C; Valles JM; Capelastegui A; Marcos MA; Alfageme I; Zalacain R; Almirall J; Molinos L; Bello S; Rodríguez F; Blanquer J; Dorado A; Llevat N; Rello J;
Thorax; 2013 Nov; 68(11):1007-14. PubMed ID: 24130227
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of healthcare-associated pneumonia in a public hospital in a metropolitan area of Japan.
Sugisaki M; Enomoto T; Shibuya Y; Matsumoto A; Saitoh H; Shingu A; Narato R; Nomura K
J Infect Chemother; 2012 Jun; 18(3):352-60. PubMed ID: 22116463
[TBL] [Abstract][Full Text] [Related]
28. Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome.
Micek ST; Reichley RM; Kollef MH
Medicine (Baltimore); 2011 Nov; 90(6):390-395. PubMed ID: 22033455
[TBL] [Abstract][Full Text] [Related]
29. Methicillin-resistant Staphylococcus aureus in community-acquired and health care-associated pneumonia: incidence, diagnosis, and treatment options.
Dean N
Hosp Pract (1995); 2010 Feb; 38(1):7-15. PubMed ID: 20469619
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
31. Performances of prognostic scoring systems in patients with healthcare-associated pneumonia.
Jeong BH; Koh WJ; Yoo H; Um SW; Suh GY; Chung MP; Kim H; Kwon OJ; Jeon K
Clin Infect Dis; 2013 Mar; 56(5):625-32. PubMed ID: 23155150
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of healthcare-associated pneumonia (HCAP).
Zilberberg MD; Shorr AF
Semin Respir Crit Care Med; 2009 Feb; 30(1):10-5. PubMed ID: 19199182
[TBL] [Abstract][Full Text] [Related]
33. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.
Carratalà J; Mykietiuk A; Fernández-Sabé N; Suárez C; Dorca J; Verdaguer R; Manresa F; Gudiol F
Arch Intern Med; 2007 Jul; 167(13):1393-9. PubMed ID: 17620533
[TBL] [Abstract][Full Text] [Related]
34. Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia.
Metersky ML; Frei CR; Mortensen EM
Respirology; 2016 Jan; 21(1):157-63. PubMed ID: 26682638
[TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals.
Hoo Lee J; Hyung Kim Y
Braz J Infect Dis; 2012; 16(4):321-8. PubMed ID: 22846118
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of the patients with community-acquired pneumonia (CAP) and health care-associated pneumonia (HCAP) requiring hospitalization.
Kara S; Akçay MŞ; Ekici Ünsal Z; Bozkurt Yılmaz HE; Habeşoğlu MA
Tuberk Toraks; 2019 Jun; 67(2):108-115. PubMed ID: 31414641
[TBL] [Abstract][Full Text] [Related]
37. Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia.
Giannella M; Pinilla B; Capdevila JA; Martínez Alarcón J; Muñoz P; López Álvarez J; Bouza E;
Clin Microbiol Infect; 2012 Aug; 18(8):786-94. PubMed ID: 22284436
[TBL] [Abstract][Full Text] [Related]
38. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.
Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM
J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845
[TBL] [Abstract][Full Text] [Related]
39. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
[TBL] [Abstract][Full Text] [Related]
40. Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia.
Taneja C; Haque N; Oster G; Shorr AF; Zilber S; Kyan PO; Reyes KC; Moore C; Spalding J; Kothari S; Zervos M
J Hosp Med; 2010; 5(9):528-34. PubMed ID: 20734457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
